Fig. 3

Kaplan-Meier curve of the 30-day survival probability of all patients with CRE BSI (a) patients with and without septic shock (b) patients with and without pulmonary infection (c) patients with ceftazidime-avibactam (CAZ-AVI) or other active antibiotics (OAAs) treatment (d)